The DOI matches its Crossref record; 205 of the 205 references it cites were found in a registry or an index.
Immune Responses Regulated by Cannabidiol
Open accessAbstract
Introduction: Cannabidiol (CBD) as Epidiolex ® (GW Pharmaceuticals) was recently approved by the U.S. Food and Drug Administration (FDA) to treat rare forms of epilepsy in patients 2 years of age and older. Together with the increased societal acceptance of recreational cannabis and CBD oil for putative medical use in many states, the exposure to CBD is increasing, even though all of its biological effects are not understood. Once such example is the ability of CBD to be anti-inflammatory and immune suppressive, so the purpose of this review is to summarize effects and mechanisms of CBD in the immune system. It includes a consideration of reports identifying receptors through which CBD acts, since the “CBD receptor,” if a single one exists, has not been definitively identified for the myriad immune system effects. The review then provides a summary of in vivo and in vitro effects in the immune system, in autoimmune models, with a focus on experimental autoimmune encephalomyelitis, and ends with identification of knowledge gaps. Conclusion: Overall, the data overwhelmingly support the notion that CBD is immune suppressive and that the mechanisms involve direct suppression of activation of various immune cell types, induction of apoptosis, and promotion of regulatory cells, which, in turn, control other immune cell targets.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor
Devane, W. A., Hanuš, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., & Mechoulam, R. (1992) · Science · doi:10.1126/science.1470919 · Cited by 5,633
Molecular characterization of a peripheral receptor for cannabinoids
Munro, S., Thomas, K. L., & Abu-Shaar, M. (1993) · Nature · doi:10.1038/365061a0 · Cited by 5,092
Structure of a cannabinoid receptor and functional expression of the cloned cDNA
Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C., & Bonner, T. I. (1990) · Nature · doi:10.1038/346561a0 · Cited by 5,011
Isolation, Structure, and Partial Synthesis of an Active Constituent of Hashish
Gaoni, Y., & Mechoulam, R. (1964) · Journal of the American Chemical Society · doi:10.1021/ja01062a046 · Cited by 2,393
Immunopathology of multiple sclerosis
Dendrou, C. A., Fugger, L., & Friese, M. A. (2015) · Nature Reviews Immunology · doi:10.1038/nri3871 · Cited by 2,215
Zhou, L., Ivanov, I. I., Spolski, R., Min, R., Shenderov, K., Egawa, T., Levy, D. E., Leonard, W. J., & Littman, D. R. (2007) · Nature Immunology · doi:10.1038/ni1488 · Cited by 2,141
The orphan receptor GPR55 is a novel cannabinoid receptor
Ryberg, E., Larsson, N., Sjögren, S., Hjorth, S., Hermansson, N., Leonova, J., Elebring, T., Nilsson, K., Drmota, T., & Greasley, P. J. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707460 · Cited by 1,568
Bisogno, T., Hanuš, L., De Petrocellis, L., Tchilibon, S., Ponde, D. E., Brandi, I., Moriello, A. S., Davis, J. B., Mechoulam, R., & Di Marzo, V. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704327 · Cited by 1,311
Cannabidiol is a negative allosteric modulator of the cannabinoid CB 1 receptor
Laprairie, R. B., Bagher, A. M., Kelly, M. E. M., & Denovan‐Wright, E. M. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13250 · Cited by 1,039
De Petrocellis, L., Ligresti, A., Moriello, A. S., Allarà, M., Bisogno, T., Petrosino, S., Stott, C. G., & Di Marzo, V. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01166.x · Cited by 946
Thiele, E. A., Marsh, E. D., French, J. A., Mazurkiewicz-Beldzinska, M., Benbadis, S. R., Joshi, C., Lyons, P. D., Taylor, A., Roberts, C., Sommerville, K., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30136-3 · Cited by 905
Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial
Devinsky, O., Marsh, E., Friedman, D., Thiele, E., Laux, L., Sullivan, J., Miller, I., Flamini, R., Wilfong, A., Filloux, F., et al. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(15)00379-8 · Cited by 900
Agonistic properties of cannabidiol at 5-HT1a receptors
Russo, E. B., Burnett, A., Hall, B., & Parker, K. K. (2005) · Neurochemical Research · doi:10.1007/s11064-005-6978-1 · Cited by 878
Zajicek, J., Fox, P., Sanders, H., Wright, D., Vickery, J., Nunn, A., & Thompson, A. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14738-1 · Cited by 827
Bergamaschi, M. M., Queiroz, R. H. C., Chagas, M. H. N., de Oliveira, D. C. G., De Martinis, B. S., Kapczinski, F., Quevedo, J., Roesler, R., Schröder, N., Nardi, A. E., et al. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.6 · Cited by 771
Regulation of the expression of inducible nitric oxide synthase
Kleinert, H., Pautz, A., Linker, K., & Schwarz, P. M. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.07.030 · Cited by 705
Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis
Rog, D. J., Nurmikko, T. J., Friede, T., & Young, C. A. (2005) · Neurology · doi:10.1212/01.wnl.0000176753.45410.8b · Cited by 679
Malfait, A. M., Gallily, R., Sumariwalla, P. F., Malik, A. S., Andreakos, E., Mechoulam, R., & Feldmann, M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.160105897 · Cited by 669
Nonpsychotropic Cannabinoid Receptors Regulate Microglial Cell Migration
Walter, L., Franklin, A., Witting, A., Wade, C., Xie, Y., Kunos, G., Mackie, K., & Stella, N. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-04-01398.2003 · Cited by 665
Facci, L., Dal Toso, R., Romanello, S., Buriani, A., Skaper, S. D., & Leon, A. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.8.3376 · Cited by 632
McGuire, P., Robson, P., Cubala, W. J., Vasile, D., Morrison, P. D., Barron, R., Taylor, A., & Wright, S. (2018) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2017.17030325 · Cited by 617
Wade, D. T., Makela, P., Robson, P., House, H., & Bateman, C. (2004) · Multiple Sclerosis Journal · doi:10.1191/1352458504ms1082oa · Cited by 589
Crippa, J. A. S., Derenusson, G. N., Ferrari, T. B., Wichert-Ana, L., Duran, F. L., Martin-Santos, R., Simões, M. V., Bhattacharyya, S., Fusar-Poli, P., Atakan, Z., et al. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881110379283 · Cited by 535
Rajesh, M., Mukhopadhyay, P., Bátkai, S., Patel, V., Saito, K., Matsumoto, S., Kashiwaya, Y., Horváth, B., Mukhopadhyay, B., Becker, L., et al. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.07.033 · Cited by 499
Carrier, E. J., Auchampach, J. A., & Hillard, C. J. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0511232103 · Cited by 497
Mechoulam, R., & Shvo, Y. (1963) · Tetrahedron · doi:10.1016/0040-4020(63)85022-x · Cited by 486
Novotna, A., Mares, J., Ratcliffe, S., Novakova, I., Vachova, M., Zapletalova, O., Gasperini, C., Pozzilli, C., Cefaro, L., Comi, G., et al. (2011) · European Journal of Neurology · doi:10.1111/j.1468-1331.2010.03328.x · Cited by 475
Randomized, dose-ranging safety trial of cannabidiol in Dravet syndrome
Devinsky, O., Patel, A. D., Thiele, E. A., Wong, M. H., Appleton, R., Harden, C. L., Greenwood, S., Morrison, G., Sommerville, K., On behalf of the GWPCARE1 Part A Study Group, et al. (2018) · Neurology · doi:10.1212/wnl.0000000000005254 · Cited by 458
Blake, D. R., Robson, P., Ho, M., Jubb, R. W., & McCabe, C. S. (2006) · Rheumatology · doi:10.1093/rheumatology/kei183 · Cited by 433
Nurmikko, T. J., Serpell, M. G., Hoggart, B., Toomey, P. J., Morlion, B. J., & Haines, D. (2007) · Pain · doi:10.1016/j.pain.2007.08.028 · Cited by 431
Iannotti, F. A., Hill, C. L., Leo, A., Alhusaini, A., Soubrane, C., Mazzarella, E., Russo, E., Whalley, B. J., Di Marzo, V., & Stephens, G. J. (2014) · ACS Chemical Neuroscience · doi:10.1021/cn5000524 · Cited by 413
Esposito, G., Scuderi, C., Valenza, M., Togna, G. I., Latina, V., De Filippis, D., Cipriano, M., Carratù, M. R., Iuvone, T., & Steardo, L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028668 · Cited by 410
Marijuana and medicine: assessing the science base
(1999) · Choice Reviews Online · doi:10.5860/choice.37-2206 · Cited by 410
Qin, N., Neeper, M. P., Liu, Y., Hutchinson, T. L., Lubin, M. L., & Flores, C. M. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.0504-08.2008 · Cited by 396
Costa, B., Trovato, A. E., Comelli, F., Giagnoni, G., & Colleoni, M. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.11.006 · Cited by 395
De Gregorio, D., McLaughlin, R. J., Posa, L., Ochoa-Sanchez, R., Enns, J., Lopez-Canul, M., Aboud, M., Maione, S., Comai, S., & Gobbi, G. (2019) · Pain · doi:10.1097/j.pain.0000000000001386 · Cited by 393
Antianxiety effect of cannabidiol in the elevated plus-maze
Guimarães, F. S., Chiaretti, T. M., Graeff, F. G., & Zuardi, A. W. (1990) · Psychopharmacology · doi:10.1007/bf02244012 · Cited by 379
Randomized controlled trial of cannabis‐based medicine in spasticity caused by multiple sclerosis
Collin, C., Davies, P., Mutiboko, I. K., Ratcliffe, S., & for the Sativex Spasticity in MS Study Group (2007) · European Journal of Neurology · doi:10.1111/j.1468-1331.2006.01639.x · Cited by 379
Cannabidiol is an allosteric modulator at mu- and delta-opioid receptors
Kathmann, M., Flau, K., Redmer, A., Tränkle, C., & Schlicker, E. (2006) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/s00210-006-0033-x · Cited by 377
Effects of ipsapirone and cannabidiol on human experimental anxiety
Zuardi, A. W., Cosme, R. A., Graeff, F. G., & Guimarães, F. S. (1993) · Journal of Psychopharmacology · doi:10.1177/026988119300700112 · Cited by 364
Campos, A. C., & Guimarães, F. S. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1168-x · Cited by 364
Maresz, K., Pryce, G., Ponomarev, E. D., Marsicano, G., Croxford, J. L., Shriver, L. P., Ledent, C., Cheng, X., Carrier, E. J., Mann, M. K., et al. (2007) · Nature Medicine · doi:10.1038/nm1561 · Cited by 363
Porter, B. E., & Jacobson, C. (2013) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2013.08.037 · Cited by 359
Pharmacokinetics, Safety, and Clinical Efficacy of Cannabidiol Treatment in Osteoarthritic Dogs
Gamble, L.-J., Boesch, J. M., Frye, C. W., Schwark, W. S., Mann, S., Wolfe, L., Brown, H., Berthelsen, E. S., & Wakshlag, J. J. (2018) · Frontiers in Veterinary Science · doi:10.3389/fvets.2018.00165 · Cited by 343
De Petrocellis, L., Vellani, V., Schiano-Moriello, A., Marini, P., Magherini, P. C., Orlando, P., & Di Marzo, V. (2008) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.134809 · Cited by 336
De Petrocellis, L., Orlando, P., Moriello, A. S., Aviello, G., Stott, C., Izzo, A. A., & Di Marzo, V. (2012) · Acta Physiologica · doi:10.1111/j.1748-1716.2011.02338.x · Cited by 323
Tham, M., Yilmaz, O., Alaverdashvili, M., Kelly, M. E. M., Denovan‐Wright, E. M., & Laprairie, R. B. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14440 · Cited by 316
Campos, A. C., Ortega, Z., Palazuelos, J., Fogaça, M. V., Aguiar, D. C., Díaz-Alonso, J., Ortega-Gutiérrez, S., Vázquez-Villa, H., Moreira, F. A., Guzmán, M., et al. (2013) · International Journal of Neuropsychopharmacology · doi:10.1017/s1461145712001502 · Cited by 313
Elmes, M. W., Kaczocha, M., Berger, W. T., Leung, K., Ralph, B. P., Wang, L., Sweeney, J. M., Miyauchi, J. T., Tsirka, S. E., Ojima, I., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.618447 · Cited by 312
Esposito, G., Scuderi, C., Savani, C., Steardo, L., De Filippis, D., Cottone, P., Iuvone, T., Cuomo, V, & Steardo, L. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707337 · Cited by 308
Transdermal cannabidiol reduces inflammation and pain‐related behaviours in a rat model of arthritis
Hammell, D. C., Zhang, L. P., Ma, F., Abshire, S. M., McIlwrath, S. L., Stinchcomb, A. L., & Westlund, K. N. (2016) · European Journal of Pain · doi:10.1002/ejp.818 · Cited by 300
Langford, R. M., Mares, J., Novotna, A., Vachova, M., Novakova, I., Notcutt, W., & Ratcliffe, S. (2013) · Journal of Neurology · doi:10.1007/s00415-012-6739-4 · Cited by 298
Costa, B., Giagnoni, G., Franke, C., Trovato, A. E., & Colleoni, M. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705920 · Cited by 289
Kozela, E., Pietr, M., Juknat, A., Rimmerman, N., Levy, R., & Vogel, Z. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.069294 · Cited by 286
Mecha, M., Feliú, A., Iñigo, P. M., Mestre, L., Carrillo-Salinas, F. J., & Guaza, C. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.06.016 · Cited by 285
Collin, C., Ehler, E., Waberzinek, G., Alsindi, Z., Davies, P., Powell, K., Notcutt, W., O'Leary, C., Ratcliffe, S., Nováková, I., et al. (2010) · Neurological Research · doi:10.1179/016164109x12590518685660 · Cited by 283
Castillo, A., Tolón, M. R., Fernández-Ruiz, J., Romero, J., & Martinez-Orgado, J. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.10.023 · Cited by 279
Cannabidiol—transdermal delivery and anti-inflammatory effect in a murine model
Lodzki, M., Godin, B., Rakou, L., Mechoulam, R., Gallily, R., & Touitou, E. (2003) · Journal of Controlled Release · doi:10.1016/j.jconrel.2003.09.001 · Cited by 268
Philpott, H. T., O'Brien, M., & McDougall, J. J. (2017) · Pain · doi:10.1097/j.pain.0000000000001052 · Cited by 268
Lynch, M. E., Cesar-Rittenberg, P., & Hohmann, A. G. (2014) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2013.02.018 · Cited by 266
Vaney, C., Heinzel-Gutenbrunner, M., Jobin, P., Tschopp, F., Gattlen, B., Hagen, U., Schnelle, M., & Reif, M. (2004) · Multiple Sclerosis Journal · doi:10.1191/1352458504ms1048oa · Cited by 262
COX-2-derived endocannabinoid metabolites as novel inflammatory mediators
Alhouayek, M., & Muccioli, G. G. (2014) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2014.03.001 · Cited by 252
Cannabidiol: an overview of some chemical and pharmacological aspects. Part I: chemical aspects
Mechoulam, R., & Hanuš, L. (2002) · Chemistry and Physics of Lipids · doi:10.1016/s0009-3084(02)00144-5 · Cited by 250
Costa, B., Colleoni, M., Conti, S., Parolaro, D., Franke, C., Trovato, A. E., & Giagnoni, G. (2004) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/s00210-004-0871-3 · Cited by 242
Cannabidiol presents an inverted U-shaped dose-response curve in a simulated public speaking test
Linares, I. M., Zuardi, A. W., Pereira, L. C., Queiroz, R. H., Mechoulam, R., Guimarães, F. S., & Crippa, J. A. (2019) · Brazilian Journal of Psychiatry · doi:10.1590/1516-4446-2017-0015 · Cited by 241
Johnson, J. R., Lossignol, D., Burnell-Nugent, M., & Fallon, M. T. (2013) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2012.07.014 · Cited by 236
Hložek, T., Uttl, L., Kadeřábek, L., Balíková, M., Lhotková, E., Horsley, R. R., Nováková, P., Šíchová, K., Štefková, K., Tylš, F., et al. (2017) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2017.10.037 · Cited by 234
Pazos, M. R., Mohammed, N., Lafuente, H., Santos, M., Martínez-Pinilla, E., Moreno, E., Valdizan, E., Romero, J., Pazos, A., Franco, R., et al. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.03.027 · Cited by 225
Self-management strategies amongst Australian women with endometriosis: a national online survey
Armour, M., Sinclair, J., Chalmers, K. J., & Smith, C. A. (2019) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-019-2431-x · Cited by 221
Hussain, S. A., Zhou, R., Jacobson, C., Weng, J., Cheng, E., Lay, J., Hung, P., Lerner, J. T., & Sankar, R. (2015) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2015.04.009 · Cited by 220
Naftali, T., Mechulam, R., Marii, A., Gabay, G., Stein, A., Bronshtain, M., Laish, I., Benjaminov, F., & Konikoff, F. M. (2017) · Digestive Diseases and Sciences · doi:10.1007/s10620-017-4540-z · Cited by 216
Cannabidiol lowers incidence of diabetes in non-obese diabetic mice
Weiss, L., Zeira, M., Reich, S., Har-Noy, M., Mechoulam, R., Slavin, S., & Gallily, R. (2006) · Autoimmunity · doi:10.1080/08916930500356674 · Cited by 215
McKallip, R. J., Jia, W., Schlomer, J., Warren, J. W., Nagarkatti, P. S., & Nagarkatti, M. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.023937 · Cited by 211
Rajesh, M., Mukhopadhyay, P., Bátkai, S., Haskó, G., Liaudet, L., Drel, V. R., Obrosova, I. G., & Pacher, P. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00236.2007 · Cited by 209
Anxiolytic-like effect of cannabidiol in the rat Vogel conflict test
Moreira, F. A., Aguiar, D. C., & Guimarães, F. S. (2006) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2006.06.004 · Cited by 207
Fogaça, M. V., Campos, A. C., Coelho, L. D., Duman, R. S., & Guimarães, F. S. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.03.001 · Cited by 207
Mukhopadhyay, P., Rajesh, M., Horváth, B., Bátkai, S., Park, O., Tanchian, G., Gao, R. Y., Patel, V., Wink, D. A., Liaudet, L., et al. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.02.021 · Cited by 205
COX-2 and PPAR-γ Confer Cannabidiol-Induced Apoptosis of Human Lung Cancer Cells
Ramer, R., Heinemann, K., Merkord, J., Rohde, H., Salamon, A., Linnebacher, M., & Hinz, B. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-12-0335 · Cited by 202
Martínez-Pinilla, E., Varani, K., Reyes-Resina, I., Angelats, E., Vincenzi, F., Ferreiro-Vera, C., Oyarzabal, J., Canela, E. I., Lanciego, J. L., Nadal, X., et al. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00744 · Cited by 199
Kozela, E., Lev, N., Kaushansky, N., Eilam, R., Rimmerman, N., Levy, R., Ben‐Nun, A., Juknat, A., & Vogel, Z. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01379.x · Cited by 190
Cannabidiol as a new treatment for drug‐resistant epilepsy in tuberous sclerosis complex
Hess, E. J., Moody, K. A., Geffrey, A. L., Pollack, S. F., Skirvin, L. A., Bruno, P. L., Paolini, J. L., & Thiele, E. A. (2016) · Epilepsia · doi:10.1111/epi.13499 · Cited by 190
Δ9 Tetrahydrocannabinol and cannabidiol alter cytokine production by human immune cells
Srivastava, M. D., Srivastava, B. I. S., & Brouhard, B. (1998) · Immunopharmacology · doi:10.1016/s0162-3109(98)00041-1 · Cited by 189
Selvarajah, D., Gandhi, R., Emery, C. J., & Tesfaye, S. (2010) · Diabetes Care · doi:10.2337/dc09-1029 · Cited by 189
Borrelli, F., Aviello, G., Romano, B., Orlando, P., Capasso, R., Maiello, F., Guadagno, F., Petrosino, S., Capasso, F., Di Marzo, V., et al. (2009) · Journal of Molecular Medicine · doi:10.1007/s00109-009-0512-x · Cited by 188
ROG, D., NURMIKKO, T., & YOUNG, C. (2007) · Clinical Therapeutics · doi:10.1016/j.clinthera.2007.09.013 · Cited by 187 · cited 1×
“…performed have shown that Sativex has beneficial effects on spasticity, mobility, bladder function, and pain in MS patients, and is well tolerated 22,25,28,31,168–175 ; however, there has been little focus on the neuroprotective and immunosuppressive effects of THC:CBD mixtures in MS, and so it is…”
Nadulski, T., Pragst, F., Weinberg, G., Roser, P., Schnelle, M., Fronk, E.-M., & Stadelmann, A. M. (2005) · Therapeutic Drug Monitoring · doi:10.1097/01.ftd.0000177223.19294.5c · Cited by 185
Ribeiro, A., Ferraz-de-Paula, V., Pinheiro, M. L., Vitoretti, L. B., Mariano-Souza, D. P., Quinteiro-Filho, W. M., Akamine, A. T., Almeida, V. I., Quevedo, J., Dal-Pizzol, F., et al. (2012) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.12.043 · Cited by 185
Cannabidiol Reduces Intestinal Inflammation through the Control of Neuroimmune Axis
De Filippis, D., Esposito, G., Cirillo, C., Cipriano, M., De Winter, B. Y., Scuderi, C., Sarnelli, G., Cuomo, R., Steardo, L., De Man, J. G., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028159 · Cited by 173
Randomized controlled trial of Sativex to treat detrusor overactivity in multiple sclerosis
Kavia, R., De Ridder, D., Constantinescu, C., Stott, C., & Fowler, C. (2010) · Multiple Sclerosis Journal · doi:10.1177/1352458510378020 · Cited by 173
Petrosino, S., Verde, R., Vaia, M., Allarà, M., Iuvone, T., & Marzo, V. D. (2018) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.117.244368 · Cited by 166
Notcutt, W., Langford, R., Davies, P., Ratcliffe, S., & Potts, R. (2012) · Multiple Sclerosis Journal · doi:10.1177/1352458511419700 · Cited by 165
Scuderi, C., Steardo, L., & Esposito, G. (2014) · Phytotherapy Research · doi:10.1002/ptr.5095 · Cited by 161
Toth, C. C., Jedrzejewski, N. M., Ellis, C. L., & Frey, W. H. (2010) · Molecular Pain · doi:10.1186/1744-8069-6-16 · Cited by 160
Hind, W. H., England, T. J., & O’Sullivan, S. E. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13368 · Cited by 158
Sartim, A. G., Guimarães, F. S., & Joca, S. R. L. (2016) · Behavioural Brain Research · doi:10.1016/j.bbr.2016.01.033 · Cited by 156
Flachenecker, P., Henze, T., & Zettl, U. K. (2014) · European Neurology · doi:10.1159/000357427 · Cited by 156
Liou, G. I., Auchampach, J. A., Hillard, C. J., Zhu, G., Yousufzai, B., Mian, S., Khan, S. H., & Khalifa, Y. M. (2008) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.08-2196 · Cited by 154
Giacoppo, S., Pollastro, F., Grassi, G., Bramanti, P., & Mazzon, E. (2016) · Fitoterapia · doi:10.1016/j.fitote.2016.11.010 · Cited by 152
CD83: an update on functions and prospects of the maturation marker of dendritic cells
Prechtel, A. T., & Steinkasserer, A. (2007) · Archives of Dermatological Research · doi:10.1007/s00403-007-0743-z · Cited by 150
Cannabidiol arrests onset of autoimmune diabetes in NOD mice
Weiss, L., Zeira, M., Reich, S., Slavin, S., Raz, I., Mechoulam, R., & Gallily, R. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.06.029 · Cited by 147
Magen, I., Avraham, Y., Ackerman, Z., Vorobiev, L., Mechoulam, R., & Berry, E. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00589.x · Cited by 143
Kaplan, B. L. F., Springs, A. E. B., & Kaminski, N. E. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.06.022 · Cited by 143
Self-citationPharmacological Effects of Cannabinoids on the Caco-2 Cell Culture Model of Intestinal Permeability
Alhamoruni, A., Lee, A. C., Wright, K. L., Larvin, M., & O’Sullivan, S. E. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.168237 · Cited by 141
Hassan, S., Eldeeb, K., Millns, P. J., Bennett, A. J., Alexander, S. P. H., & Kendall, D. A. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12615 · Cited by 138
Cannabinoids mediate opposing effects on inflammation‐induced intestinal permeability
Alhamoruni, A., Wright, K. L., Larvin, M., & O’Sullivan, S. E. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01589.x · Cited by 138
McHugh, D., Tanner, C., Mechoulam, R., Pertwee, R. G., & Ross, R. A. (2007) · Molecular Pharmacology · doi:10.1124/mol.107.041863 · Cited by 136
Durst, R. Y., Danenberg, H. D., Gallily, R., Mechoulam, R., Meir, K., Grad, E., Beeri, R., Pugatsch, T., Tarsish, E., & Lotan, C. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00098.2007 · Cited by 134
Hegde, V. L., Nagarkatti, P. S., & Nagarkatti, M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018281 · Cited by 133
Wang, Y., Mukhopadhyay, P., Cao, Z., Wang, H., Feng, D., Haskó, G., Mechoulam, R., Gao, B., & Pacher, P. (2017) · Scientific Reports · doi:10.1038/s41598-017-10924-8 · Cited by 131
Sacerdote, P., Martucci, C., Vaccani, A., Bariselli, F., Panerai, A. E., Colombo, A., Parolaro, D., & Massi, P. (2005) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2004.10.003 · Cited by 130
Jamontt, J., Molleman, A., Pertwee, R. G., & Parsons, M. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00791.x · Cited by 129
Elliott, D. M., Singh, N. P., Nagarkatti, M., & Nagarkatti, P. S. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01782 · Cited by 129
Pagano, E., Capasso, R., Piscitelli, F., Romano, B., Parisi, O. A., Finizio, S., Lauritano, A., Marzo, V. D., Izzo, A. A., & Borrelli, F. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00341 · Cited by 128
Rajan, T. S., Giacoppo, S., Iori, R., Nicola, G. R. D., Grassi, G., Pollastro, F., Bramanti, P., & Mazzon, E. (2016) · Fitoterapia · doi:10.1016/j.fitote.2016.05.008 · Cited by 127
Ruiz‐Valdepeñas, L., Martínez-Orgado, J. A., Benito, C., Millán‐Uclés, Á., Tolón, R. M., & Romero, J. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-5 · Cited by 125
Cannabidiol reduces airway inflammation and fibrosis in experimental allergic asthma
Vuolo, F. S., Abreu, S. C., Michels, M., Xisto, D. G., Blanco, N. G., Hallak, J. E. C., Zuardi, A. W., Crippa, J. A., dos Reis, C. M., Bahl, M., et al. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.11.029 · Cited by 125
Cannabinoids Decrease the Th17 Inflammatory Autoimmune Phenotype
Kozela, E., Juknat, A., Kaushansky, N., Rimmerman, N., Ben‐Nun, A., & Vogel, Z. (2013) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-013-9493-1 · Cited by 124
Cannabidiol-Δ 9 -tetrahydrocannabinol interactions on acute pain and locomotor activity
Britch, S. C., Wiley, J. L., Yu, Z., Clowers, B. H., & Craft, R. M. (2017) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2017.01.046 · Cited by 124
Efficacy and safety of cannabinoid oromucosal spray for multiple sclerosis spasticity
Patti, F., Messina, S., Solaro, C. M., Amato, M. P., Bergamaschi, R., Bonavita, S., Bossio, R. B., Morra, V. B., Costantino, G., Cavalla, P., et al. (2016) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2015-312591 · Cited by 123
Cannabidiol, extracted fromCannabis sativa, selectively inhibits inflammatory hypermotility in mice
Capasso, R., Borrelli, F., Aviello, G., Romano, B., Scalisi, C., Capasso, F., & Izzo, A. A. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.177 · Cited by 122
Fonseca, B. M., Correia‐da‐Silva, G., & Teixeira, N. A. A. (2018) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-018-0611-7 · Cited by 120
Zgair, A., Lee, J.-B., Wong, J. C., Taha, D. A., Aram, J., Virgilio, D. D., Mcarthur, J., Cheng, Y.-K., Hennig, I., Barrett, D., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-15026-z · Cited by 117
Inhibition of Anandamide Amidase Activity in Mouse Brain Microsomes by Cannabinoids.
Watanabe, K., Kayano, Y., Matsunaga, T., Yamamoto, I., & Yoshimura, H. (1996) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.19.1109 · Cited by 116
Ribeiro, A. B., de Almeida, V. I., Costola-de-Souza, C., Ferraz-de-Paula, V., Pinheiro, M. L., Vitoretti, L. B., Gimenes-Júnior, J. A., Akamine, A. T., Crippa, J. A. S., Tavares-de-Lima, W., et al. (2014) · Immunopharmacology and Immunotoxicology · doi:10.3109/08923973.2014.976794 · Cited by 114
Rock, E. M., Limebeer, C. L., & Parker, L. A. (2018) · Psychopharmacology · doi:10.1007/s00213-018-5034-1 · Cited by 114
Stanley, C. P., Hind, W. H., Tufarelli, C., & O’Sullivan, S. E. (2015) · Cardiovascular Research · doi:10.1093/cvr/cvv179 · Cited by 112
Watzl, B., Scuderi, P., & WATSON, R. R. (1991) · International Journal of Immunopharmacology · doi:10.1016/0192-0561(91)90160-9 · Cited by 111
Wu, H., Huang, C., Lin, Y., Wang, C., & Jan, T. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.06.023 · Cited by 109
Sekar, K., & Pack, A. M. (2019) · F1000Research · doi:10.12688/f1000research.16515.1 · Cited by 109
Thapa, D., Cairns, E. A., Szczesniak, A.-M., Toguri, J. T., Caldwell, M. D., & Kelly, M. E. M. (2018) · Cannabis and Cannabinoid Research · doi:10.1089/can.2017.0041 · Cited by 107
Juknat, A., Pietr, M., Kozela, E., Rimmerman, N., Levy, R., Coppola, G., Geschwind, D. H., & Vogel, Z. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01461.x · Cited by 106
Riva, N., Mora, G., Sorarù, G., Lunetta, C., Ferraro, O. E., Falzone, Y., Leocani, L., Fazio, R., Comola, M., Comi, G., et al. (2019) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30406-x · Cited by 104
Enantiomeric cannabidiol derivatives: synthesis and binding to cannabinoid receptors
Hanu, L. O., Tchilibon, S., Ponde, D. E., Breuer, A., Fride, E., & Mechoulam, R. (2005) · Organic & Biomolecular Chemistry · doi:10.1039/b416943c · Cited by 104
de Almeida, V., Levin, R. R., Peres, F. F., Niigaki, S. T., Calzavara, M. B., Zuardi, A. W., Hallak, J. E. C., Crippa, J. A. S., & Abílio, V. C. (2012) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.10.024 · Cited by 103
Chiurchiù, V., Lanuti, M., Bardi, M. D., Battistini, L., & Maccarrone, M. (2014) · International Immunology · doi:10.1093/intimm/dxu097 · Cited by 103
Campos, A. C., Brant, F., de Miranda, A. S., Machado, F. S., & Teixeira, A. L. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2014.12.051 · Cited by 102
Navarro, G., Reyes‐Resina, I., Rivas‐Santisteban, R., de Medina, V. S., Morales, P., Casano, S., Ferreiro‐Vera, C., Lillo, A., Aguinaga, D., Jagerovic, N., et al. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.08.046 · Cited by 102
Cannabidiol and palmitoylethanolamide are anti-inflammatory in the acutely inflamed human colon
Couch, D. G., Tasker, C., Theophilidou, E., Lund, J. N., & O’Sullivan, S. E. (2017) · Clinical Science · doi:10.1042/cs20171288 · Cited by 98
Regulatory Status of Cannabidiol in the United States: A Perspective
Corroon, J., & Kight, R. (2018) · Cannabis and Cannabinoid Research · doi:10.1089/can.2018.0030 · Cited by 98
Cassol-Jr, O. J., Comim, C. M., Silva, B. R., Hermani, F. V., Constantino, L. S., Felisberto, F., Petronilho, F., Hallak, J. E. C., De Martinis, B. S., Zuardi, A. W., et al. (2010) · Brain Research · doi:10.1016/j.brainres.2010.06.023 · Cited by 94
Wu, H., Chu, R., Wang, C., Lee, C.-Y., Lin, S., & Jan, T. (2007) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2007.09.012 · Cited by 94
Cannabidiol and epilepsy: Rationale and therapeutic potential
Leo, A., Russo, E., & Elia, M. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.03.005 · Cited by 93
Hegde, V. L., Singh, U. P., Nagarkatti, P. S., & Nagarkatti, M. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1401844 · Cited by 92
A comparative study on cannabidiol-induced apoptosis in murine thymocytes and EL-4 thymoma cells
Lee, C.-Y., Wey, S., Liao, M.-H., Hsu, W., Wu, H., & Jan, T. (2008) · International Immunopharmacology · doi:10.1016/j.intimp.2008.01.018 · Cited by 91
Schoedel, K. A., Chen, N., Hilliard, A., White, L., Stott, C. G., Russo, E. B., Wright, S., Guy, G. W., Romach, M. K., & Sellers, E. M. (2011) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.1196 · Cited by 90
Sands, T. T., Rahdari, S., Oldham, M. S., Nunes, E. C., Tilton, N., & Cilio, M. R. (2018) · CNS Drugs · doi:10.1007/s40263-018-0589-2 · Cited by 90
Lee, W.-S., Erdélyi, K., Mátyás, C., Mukhopadhyay, P., Varga, Z. V., Liaudet, L., Haskó, G., Čiháková, D., Mechoulam, R., & Pacher, P. (2016) · Molecular Medicine · doi:10.2119/molmed.2016.00007 · Cited by 89
Kozela, E., Juknat, A., Gao, F., Kaushansky, N., Coppola, G., & Vogel, Z. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0603-x · Cited by 88
Hayakawa, K., Mishima, K., Nozako, M., Hazekawa, M., Irie, K., Fujioka, M., Orito, K., Abe, K., Hasebe, N., Egashira, N., et al. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04565.x · Cited by 87
Abdouh, M., Storring, J. M., Riad, M., Paquette, Y., Albert, P. R., Drobetsky, E. A., & Kouassi, É. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m004559200 · Cited by 86
Evidence for Cannabinoid Receptor-Dependent and -Independent Mechanisms of Action in Leukocytes
Kaplan, B. L. F., Rockwell, C. E., & Kaminski, N. E. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.051961 · Cited by 83
Self-citationHwang, Y. S., Kim, Y., Kim, M., Kang, M., Oh, S. W., Nho, Y. H., Park, S., & Lee, J. (2017) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2017.06.005 · Cited by 83
Rahimi, A., Faizi, M., Talebi, F., Noorbakhsh, F., Kahrizi, F., & Naderi, N. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.01.030 · Cited by 82
Libro, R., Scionti, D., Diomede, F., Marchisio, M., Grassi, G., Pollastro, F., Piattelli, A., Bramanti, P., Mazzon, E., & Trubiani, O. (2016) · Frontiers in Physiology · doi:10.3389/fphys.2016.00559 · Cited by 81
Evaluation of Serum Cytokines Levels and the Role of Cannabidiol Treatment in Animal Model of Asthma
Vuolo, F. S., Petronilho, F. C., Sonai, B., Ritter, C., Hallak, J. E. C., Zuardi, A. W., Crippa, J. A. S., & Dal‐Pizzol, F. (2015) · Mediators of Inflammation · doi:10.1155/2015/538670 · Cited by 80
Filippis, D. D., Iuvone, T., D’Amico, A., Esposito, G., Steardo, L., Herman, A. G., Pelckmans, P. A., Winter, B. Y. D., & Man, J. G. D. (2008) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2008.01114.x · Cited by 80
Bornheim, L. M., Kim, K. Y., Li, J., Perotti, B. Y. T., & Benet, L. Z. (1995) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)06664-4 · Cited by 79
Sonego, A. B., Prado, D. D. S., do Vale, G. T., Sepulveda-Diaz, J. E., Cunha, T. M., Tirapelli, C. R., Bel, E. A. D., Raisman‐Vozari, R., & Guimarães, F. S. (2018) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2018.09.014 · Cited by 79
Tetrahydrocannabinol inhibition of macrophage nitric oxide production
Coffey, R. G., Yamamoto, Y., Snella, E. M., & Pross, S. H. (1996) · Biochemical Pharmacology · doi:10.1016/0006-2952(96)00356-5 · Cited by 77
Barichello, T., Ceretta, R. A., Generoso, J. S., Moreira, A. P., Simões, L. R., Comim, C. M., Quevedo, J., Vilela, M. C., Zuardi, A. W., Crippa, J. A., et al. (2012) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2012.09.053 · Cited by 76
Anti-Inflammatory Role of Cannabidiol and O-1602 in Cerulein-Induced Acute Pancreatitis in Mice
Li, K., Feng, J., Li, Y., Yuece, B., Lin, X., Yu, L.-Y., Li, Y., Feng, Y.-J., & Storr, M. (2012) · Pancreas · doi:10.1097/mpa.0b013e318259f6f0 · Cited by 76
Russo, M., Naro, A., Leo, A., Sessa, E., D’Aleo, G., Bramanti, P., & Calabrò, R. S. (2016) · Pain Medicine · doi:10.1093/pm/pnv080 · Cited by 74
Juknat, A., Gao, F., Coppola, G., Vogel, Z., & Kozela, E. (2019) · PLoS ONE · doi:10.1371/journal.pone.0212039 · Cited by 74
Gallily, R., Even-Chen, T., Katzavian, G., Lehmann, D., Dagan, A., & Mechoulam, R. (2003) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/1042819031000103917 · Cited by 70
Experimental cannabidiol treatment reduces early pancreatic inflammation in type 1 diabetes
Lehmann, C., Fisher, N. B., Tugwell, B. D., Szczesniak, A. M., Kelly, M. E. M., & Zhou, J. (2016) · Clinical Hemorheology and Microcirculation · doi:10.3233/ch-168021 · Cited by 70
Li, H., Kong, W., Chambers, C. R., Yu, D., Ganea, D., Tuma, R. F., & Ward, S. J. (2018) · Cellular Immunology · doi:10.1016/j.cellimm.2018.02.016 · Cited by 70
Kozela, E., Juknat, A., Kaushansky, N., Ben‐Nun, A., Coppola, G., & Vogel, Z. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0273-0 · Cited by 63
Jan, T., Su, S.-T., Wu, H., & Liao, M.-H. (2007) · International Immunopharmacology · doi:10.1016/j.intimp.2007.01.015 · Cited by 61
Endocannabinoid metabolism by cytochrome P450 monooxygenases
Zelasko, S. E., Arnold, W. R., & Das, A. (2014) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2014.11.002 · Cited by 61
Zettl, U. K., Rommer, P. S., Hipp, P., & Patejdl, R. (2015) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756285615612659 · Cited by 61
Messina, S., Solaro, C. M., Righini, I., Bergamaschi, R., Bonavita, S., Bossio, R. B., Morra, V. B., Costantino, G., Cavalla, P., Centonze, D., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0180651 · Cited by 59
Jenny, M., Santer, E., Pirich, E., Schennach, H., & Fuchs, D. (2009) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2008.12.004 · Cited by 58
Klein, M. J., BORTOLLI, J. D. Q. D., Guimarães, F. S., Salum, F. G., Cherubini, K., & de Figueiredo, M. A. Z. (2018) · Phytotherapy Research · doi:10.1002/ptr.6165 · Cited by 56
Cannabidiol (CBD) enhances lipopolysaccharide (LPS)-induced pulmonary inflammation in C57BL/6 mice
Karmaus, P. W. F., Wagner, J. G., Harkema, J. R., Kaminski, N. E., & Kaplan, B. L. F. (2012) · Journal of Immunotoxicology · doi:10.3109/1547691x.2012.741628 · Cited by 54
Self-citationCannabidiol, unlike synthetic cannabinoids, triggers activation of RBL-2H3 mast cells
Giudice, E. D., Rinaldi, L., Passarotto, M., Facchinetti, F., D’Arrigo, A., Guiotto, A., Carbonare, M. D., Battistin, L., & Leon, A. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.1206738 · Cited by 54
Khaksar, S., & Bigdeli, M. R. (2017) · Brain Injury · doi:10.1080/02699052.2017.1358397 · Cited by 51
Cannabidiol (CBD) induces functional Tregs in response to low-level T cell activation
Dhital, S., Stokes, J. V., Park, N., Seo, K. S., & Kaplan, B. L. F. (2016) · Cellular Immunology · doi:10.1016/j.cellimm.2016.11.006 · Cited by 49
Self-citationWalking improvements with nabiximols in patients with multiple sclerosis
Coghe, G., Pau, M., Corona, F., Frau, J., Lorefice, L., Fenu, G., Spinicci, G., Mamusa, E., Musu, L., Massole, S., et al. (2015) · Journal of Neurology · doi:10.1007/s00415-015-7866-5 · Cited by 48
Giacoppo, S., Rajan, T. S., Galuppo, M., Pollastro, F., Grassi, G., Bramanti, P., & Mazzon, E. (2015) · PubMed · Cited by 48
Costiniuk, C. T., Saneei, Z., Routy, J., Margolese, S. L., Mandarino, E., Singer, J., Lebouché, B., Cox, J., Szabo, J., Brouillette, M., et al. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-024793 · Cited by 48
Khuja, I., Yekhtin, Z., Or, R., & Almogi‐Hazan, O. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20030668 · Cited by 47
Rimmerman, N., Juknat, A., Kozela, E., Levy, R., Bradshaw, H. B., & Vogel, Z. (2011) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-011-9692-3 · Cited by 46
Cannabidiol affects circadian clock core complex and its regulation in microglia cells
Lafaye, G., Desterke, C., Marulaz, L., & Benyamina, A. (2018) · Addiction Biology · doi:10.1111/adb.12660 · Cited by 45
Reithmeier, D., Tang‐Wai, R., Seifert, B. W., Lyon, A. W., Alcorn, J., Acton, B. V., Corley, S. D., Prosser-Loose, E. J., Mousseau, D. D., Lim, H. J., et al. (2018) · BMC Pediatrics · doi:10.1186/s12887-018-1191-y · Cited by 42
Cannabidiol-induced lymphopenia does not involve NKT and NK cells.
Ignatowska-Jankowska, B. M., Jankowski, M. M., Glac, W., & Swiergel, A. H. (2009) · PubMed · Cited by 41
González‐García, C., Moreno‐Torres, I., García-Hernández, R., Campos-Ruíz, L., Rodríguez‐Esparragoza, L., Coronado, M. J., Grande, A. G., García‐Merino, A., & Sánchez, A. (2017) · Experimental Neurology · doi:10.1016/j.expneurol.2017.08.017 · Cited by 41
Watzl, B., Scuderi, P., & WATSON, R. R. (1991) · Advances in experimental medicine and biology · doi:10.1007/978-1-4684-5925-8_7 · Cited by 39
Fajardo, O., Galeno, J. G., Urbina, M., Carreira, I., & Lima, L. B. Q. (2003) · International Immunopharmacology · doi:10.1016/s1567-5769(03)00116-4 · Cited by 39
Marinelli, L., Balestrino, M., Mori, L., Puce, L., Rosa, G. M., Giorello, L., Currà, A., Fattapposta, F., Serrati, C., Gandolfo, C., et al. (2017) · BMJ Open · doi:10.1136/bmjopen-2017-016843 · Cited by 39
Cannabidiol affects the expression of genes involved in zinc homeostasis in BV-2 microglial cells
Juknat, A., Rimmerman, N., Levy, R., Vogel, Z., & Kozela, E. (2011) · Neurochemistry International · doi:10.1016/j.neuint.2011.12.002 · Cited by 37
Bigdeli, M. R., & Khaksar, S. (2017) · Basic and Clinical Neuroscience Journal · doi:10.18869/nirp.bcn.8.2.139 · Cited by 36
Cannabis Oil Use by Adolescents and Young Adults With Inflammatory Bowel Disease
Hoffenberg, E. J., McWilliams, S. K., Mikulich‐Gilbertson, S. K., Murphy, B. V., Hoffenberg, A. S., & Hopfer, C. J. (2019) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000002189 · Cited by 36
Karmaus, P. W. F., Chen, W., Kaplan, B. L. F., & Kaminski, N. E. (2011) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-011-9293-4 · Cited by 34
Self-citationWu, H.-Y., Chang, A.-C., Wang, C., Kuo, F.-H., Lee, C.-Y., Liu, D.-Z., & Jan, T. (2010) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2010.05.003 · Cited by 33
Magnitude of stimulation dictates the cannabinoid-mediated differential T cell response to HIVgp120
Chen, W., Kaplan, B. L. F., Pike, S., Topper, L. A., Lichorobiec, N. R., Simmons, S. O., Ramabhadran, R., & Kaminski, N. E. (2012) · Journal of Leukocyte Biology · doi:10.1189/jlb.0212082 · Cited by 31
Self-citationLiu, D.-Z., Hu, C.-M., Huang, C.-H., Wey, S., & Jan, T. (2010) · Acta Pharmacologica Sinica · doi:10.1038/aps.2010.155 · Cited by 28
Baban, B., Hoda, N., Malik, A., Khodadadi, H., Simmerman, E. L., Vaibhav, K., & Mozaffari, M. S. (2018) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00112.2018 · Cited by 28
Cannabidiol‐induced apoptosis in murine microglial cells through lipid raft
Wu, H., Goble, K., Mecha, M., Wang, C., Huang, C., Guaza, C., & Jan, T. (2012) · Glia · doi:10.1002/glia.22345 · Cited by 27
Henriquez, J. E., Rizzo, M. D., Schulz, M. A., Crawford, R. B., Gulick, P. G., & Kaminski, N. E. (2017) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000001449 · Cited by 27
Serra, I., Scheldeman, C., Bazelot, M., Whalley, B. J., Dallas, M. L., de Witte, P. A. M., & Williams, C. M. (2019) · Behavioural Brain Research · doi:10.1016/j.bbr.2019.01.040 · Cited by 25
Cited by
Cannabidiol: pharmacology and therapeutic targets
Britch, S. C., Babalonis, S., & Walsh, S. L. (2021) · Psychopharmacology · doi:10.1007/s00213-020-05712-8 · Cited by 307
A narrative review of molecular mechanism and therapeutic effect of cannabidiol (CBD)
Peng, J., Fan, M., An, C., Ni, F., Huang, W., & Luo, J. (2022) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.13710 · Cited by 282
Rupasinghe, H. P. V., Davis, A., Kumar, S. K., Murray, B., & Zheljazkov, V. D. (2020) · Molecules · doi:10.3390/molecules25184078 · Cited by 260
Cannabidiol presents an inverted U-shaped dose-response curve in a simulated public speaking test
Linares, I. M., Zuardi, A. W., Pereira, L. C., Queiroz, R. H., Mechoulam, R., Guimarães, F. S., & Crippa, J. A. (2019) · Brazilian Journal of Psychiatry · doi:10.1590/1516-4446-2017-0015 · Cited by 241
Riva, N., Mora, G., Sorarù, G., Lunetta, C., Ferraro, O. E., Falzone, Y., Leocani, L., Fazio, R., Comola, M., Comi, G., et al. (2019) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30406-x · Cited by 104
Metadata
- Authors
- Nichols, J. M., & Kaplan, B. L. F.
- Venue
- Cannabis and Cannabinoid Research
- Publisher
- SAGE Publications
- Published
- 2020-03-01
- Volume
- 5
- Issue
- 1
- Pages
- 12-31
- ISSN
- 2378-8763 (ISSN-L)
- 2578-5125
- OpenAlex
- W2971750942
- Cited by
- 291
- References
- 205
- FWCI
- 16.84
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.